6533b834fe1ef96bd129cd35
RESEARCH PRODUCT
Amiodarone pulmonary toxicity
Edward C. RosenowWilliam J. MartinPhilippe Camussubject
Pulmonary and Respiratory Medicinemedicine.diagnostic_testbusiness.industryPulmonary toxicityIatrogenic DiseaseAmiodaronePneumoniaAmiodaroneBronchoalveolar LavageRespiratory Function TestsClinical PracticeBronchoalveolar lavageAnesthesiaIatrogenic diseaseHumansPleuraMedicinebusinessAnti-Arrhythmia AgentsLungmedicine.drugdescription
The amount of literature on amiodarone pulmonary toxicity (APT) peaked in 1983-1984 with several hundred cases reported cumulatively, and declined thereafter. Since the mid-1990s, publications have increased, which suggests that APT remains a current problem in clinical practice. Amiodarone remains difficult to diagnose noninvasively, and although the outcome is good in the majority of patients, not all cases of APT can be controlled satisfactorily.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2004-04-06 | Clinics in Chest Medicine |